Showing results (21-30 of 314) with videos related to
Sort By:
Pageof 32
Arthritis Research & Therapy|February 24, 2009
Developments in the clinical understanding of rheumatoid arthritisJosef S Smolen, Daniel AletahaRheumatic Diseases Clinics of North America|July 7, 2019
Does Triple Conventional Synthetic Disease-Modifying Antirheumatic Drug Therapy Improve upon Methotrexate as the Initial Treatment of Choice for a Rheumatoid Arthritis Patient?Daniel Aletaha, Josef S SmolenRheumatic Diseases Clinics of North America|March 1, 2006
The definition and measurement of disease modification in inflammatory rheumatic diseasesDaniel Aletaha, Josef S SmolenBest Practice & Research. Clinical Rheumatology|August 7, 2007
The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical careDaniel Aletaha, Josef S SmolenClinical and Experimental Rheumatology|June 26, 2010
The assessment of disease activity in rheumatoid arthritisJosef S Smolen, Daniel AletahaCurrent Opinion in Rheumatology|April 5, 2008
Activity assessments in rheumatoid arthritisJosef S Smolen, Daniel AletahaThe Journal of Rheumatology. Supplement|March 3, 2011
Diagnostic and prognostic value of antibodies and soluble biomarkers in undifferentiated peripheral inflammatory arthritis: a systematic reviewMonika Schoels, Claire Bombardier, Daniel AletahaBest Practice & Research. Clinical Rheumatology|February 24, 2009
The use of data from early arthritis clinics for clinical researchDaniel Aletaha, T W J HuizingaAnnals of the Rheumatic Diseases|October 15, 2009
Impact of comorbidity on physical function in patients with rheumatoid arthritisHelga Radner, Josef S Smolen, Daniel AletahaAnnals of the Rheumatic Diseases|October 1, 2015
Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time pointDaniel Aletaha, Farideh Alasti, Josef S SmolenPageof 32